About Dermasensor
Dermasensor is a private company based in Miami, Florida. It has reported $29,151,392 raised in four offerings on Form D since December 2018. Its chief executive is Cody Simmons.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | Dec 5, 2024 | $8,929,505of $17.0M target | 41 | $217K | EquityRule 506(b) | Form D ↗ |
| Dec 3, 2021 | Dec 21, 2021 | $8,509,389of $10.0M target | 168 | $50,651 | EquityRule 506(b) | Form D ↗ |
| Feb 27, 2020 | Mar 17, 2020 | $5,904,647of $10.0M target | 97 | $60,873 | EquityRule 506(b) | Form D ↗ |
| Nov 1, 2018 | Dec 19, 2018 | $5,807,851target not set | 23 | $252K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $29,151,392 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Dermasensor's Form D filed Dec 5, 2024.
Christopher Dewey
Director
Also a director at MIVI Neuroscience and Radom and an executive chairman at Accuryn Medical.
CS
Cody Simmons
Chief Executive Officer and director
DM
Earlier filings also listed Ivan Delevic (director, last listed Mar 2020) and Cristiane Benvenuto (chief medical officer, last listed Mar 2020).